Chapter 14 Peripheral nerve hyperexcitability and the neuromuscular junction

Handbook of Clinical Neurology

Volumn 91, Issue , 2008, Pages 433-443

  Vernino, Steven ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; ELECTROMYOGRAPHY; GENETICS; HISTORY; HUMAN; METHODOLOGY; NERVE CONDUCTION; NEUROMUSCULAR SYNAPSE; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; ELECTROMYOGRAPHY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MUSCLE, SKELETAL; NEURAL CONDUCTION; NEUROMUSCULAR JUNCTION; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 66049147266     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01514-X     Document Type: Review

References (52)

1. Ansevin C., and Agamanolis D. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol 53 (1996) 197-199
2. Arimura K. Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders. Rinsho Shinkeigaku-Clin Neurol 39 (1999) 1235-1236
3. Arroyo E.J., Xu Y.T., Zhou L., et al. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J Neurocytol 28 (1999) 333-347
4. Arroyo E.J., Sirkowski E.E., Chitale R., et al. Acute demyelination disrupts the molecular organization of peripheral nervous system nodes. J Comp Neurol 479 (2004) 424-434
5. Auger R.G. AAEM Minimonograph #44: diseases associated with excess motor unit activity. Muscle Nerve 17 (1994) 1250-1263
6. Auger R.G., Daube J.R., Gomez M.R., et al. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol 15 (1984) 13-21
7. Barber P.A., Anderson N.E., and Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 54 (2000) 771-772
8. Blexrud M.D., Windebank A.J., and Daube J.R. Long-term follow-up of 121 patients with benign fasciculations. Ann Neurol 34 (1993) 622-625
9. Dedek K., Kunath B., Kananura C., et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci USA 98 (2001) 12272-12277
10. Denny-Brown D., and Foley J. Myokymia and the benign fasciculation of muscular cramps. Trans Assoc Am Physicians 61 (1948) 88-96
11. Devaux J.J., Kleopa K.A., Cooper E.C., et al. KCNQ2 is a nodal K+ channel. J Neurosci 24 (2004) 1236-1244
12. Forster F.M., Borkowski W.J., and Alpers B.J. Effects of denervation on fasciculations in human muscle. Arch Neurol Psychiatry 56 (1946) 276-283
13. Gutmann L. When is myokymia neuromyotonia?. Muscle Nerve 24 (2001) 151-153
14. Gutmann L., Tellers J.G., and Vernino S. Persistent facial myokymia associated with K(+) channel antibodies. Neurology 57 (2001) 1707-1708
15. Hart I.K., Waters C., Vincent A., et al. Autoantibodies detected to expressed potassium channels are implicated in neuromyotonia. Ann Neurol 41 (1997) 238-246
16. Hart I.K., Maddison P., Newsom-Davis J., et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 (2002) 1887-1895
17. Heijnsbroek G.J., and van Gijn J. Neostigmine-induced fasciculations-a useful diagnostic test?. Clin Neurol Neurosurg 85 (1983) 231-234
18. Herskovitz S., Song H., Cozien D., et al. Sensory symptoms in acquired neuromyotonia. Neurology 65 (2005) 1330-1331
19. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 24 (1961) 319-325
20. Josephs K.A., Silber M.H., Fealey R.D., et al. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 21 (2004) 440-445
21. Lawn N.D., Westmoreland B.F., Kiely M.J., et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78 (2003) 1363-1368
22. Layzer R.B. The origin of muscle fasciculations and cramps. Muscle Nerve 17 (1994) 1243-1249
23. Liguori R., Vincent A., Clover L., et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124 (2001) 2417-2426
24. Madrid A., Gil-Peralta A., Gil-Neciga E., et al. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol 243 (1996) 350-353
25. Mertens H.G., and Zschocke S. [Neuromyotonia]. Klin Wochenschr 43 (1965) 917-925
26. Modarres H., Samuel M., and Schon F. Isolated finger flexion: a novel form of focal neuromyotonia. J Neurol Neurosurg Psychiatry 69 (2000) 110-113
27. Morvan A. De la choree fibrillaire. Gazette hebdomadaire de médecine et de chirurgie 27 (1890) 173-176
28. Newsom-Davis J., and Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 116 (1993) 453-469
29. Riche G., Trouillas P., and Bady B. Improvement of Isaacs' syndrome after treatment with azathioprine. J Neurol Neurosurg Psychiatry 59 (1995) 448
30. Riker Jr. W.F., and Standaert F.G. The action of facilitatory drugs and acetylcholine on neuromuscular transmission. Ann N Y Acad Sci 135 (1966) 163-176
31. Roth G., and Magistris M.R. Neuropathies with prolonged conduction block, single and grouped fasciculations, localized limb myokymia. Electroencephalogr Clin Neurophysiol 67 (1987) 428-438
32. Schulte-Mattler W.J., Kley R.A., Rothenfusser-Korber E., et al. Immune-mediated rippling muscle disease. Neurology 64 (2005) 364-367
33. Shillito P., Molenaar P.C., Vincent A., et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38 (1995) 714-722
34. Sinha S., Newsom-Davis J., Mills K., et al. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 (1991) 75-77
35. Steckley J.L., Ebers G.C., Cader M.Z., et al. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 57 (2001) 1499-1502
36. Tahmoush A., Alonso R., Tahmoush G., et al. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 41 (1991) 1021-1024
37. Thieben M.J., Lennon V.A., Boeve B.F., et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62 (2004) 1177-1182
38. Tomimitsu H., Arimura K., Nagado T., et al. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia. Ann Neurol 56 (2004) 440-444
39. Torbergsen T., Stalberg E., and Brautaset N.J. Generator sites for spontaneous activity in neuromyotonia. An EMG study. Electroencephalogr Clin Neurophysiol 101 (1996) 69-78
40. Tsuneki H., Kimura I., and Dezaki K. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 196 (1995) 13-16
41. Vabnick I., Trimmer J.S., Schwarz T.L., et al. Dynamic potassium channel distributions during axonal development prevent aberrant firing patterns. J Neurosci 19 (1999) 747-758
42. van Dijk J.G., Lammers G.J., Wintzen A.R., et al. Repetitive CMAPs: mechanisms of neural and synaptic genesis. Muscle Nerve 19 (1996) 1127-1133
43. Vernino S., and Lennon V.A. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26 (2002) 702-707
44. Vernino S., and Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10 (2004) 7270-7275
45. Vernino S., Adamski J., Kryzer T.J., et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 (1998) 1806-1813
46. Vernino S., Auger R.G., Emslie-Smith A.M., et al. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 53 (1999) 1233-1239
47. Viallard J., Vincent A., Moreau J., et al. Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction. Eur Neurol 53 (2005) 60-63
48. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 (2004) 701-712
49. Wilson R.H., Lehky T., Thomas R.R., et al. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol 20 (2002) 1767-1774
50. Zhou L., Messing A., and Chiu S.Y. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves. J Neurosci 19 (1999) 5768-5781
51. Zielasek J., Martini R., Suter U., et al. Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve 23 (2000) 696-701
52. Zuberi S.M., Eunson L.H., Spauschus A., et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122 (1999) 817-825